ORTHOPEDIATRICS CORP
OrthoPediatrics Corp. (Nasdaq: KIDS) is a medical device company headquartered in Warsaw, Indiana and focused exclusively on designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions. The company operates at… From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What ORTHOPEDIATRICS CORP does
In the company’s own words
OrthoPediatrics Corp. (Nasdaq: KIDS) is a medical device company headquartered in Warsaw, Indiana and focused exclusively on designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions. The company operates at www.orthopediatrics.com and serves pediatric orthopedic surgeons and healthcare providers globally.
The company markets 87 surgical and specialized bracing systems across three primary categories: trauma and deformity correction, scoliosis treatment, and sports medicine procedures. Trauma and deformity correction generated 70 percent of revenue, scoliosis represented 28 percent, and sports medicine accounted for 2 percent. The trauma and deformity segment includes over 14,000 implants, instruments, external fixation components, and specialized braces for the femur, tibia, pelvis, and extremities. The scoliosis category features the RESPONSE systems, BandLok sub-laminar banding system, FIREFLY pedicle screw navigation guides, and the Boston 3D scoliosis brace. The company also operates multiple orthotic and prosthetic clinics delivering pediatric non-surgical treatment.
OrthoPediatrics generated revenue of $236.3 million in 2025, growing from $204.7 million in 2024 and $148.7 million in 2023, representing a compound annual growth rate of 25.2 percent since 2011. The company had consolidated total assets of $508.6 million and stockholders' equity of $346.6 million as of December 31, 2025, with 602 full-time equivalent employees.
The company employs a contract manufacturing model for implants and surgical instrumentation while manufacturing orthopedic bracing products primarily in-house. Its U.S. sales organization includes direct sales representatives and over 30 independent sales agencies employing 232 focused representatives. Internationally, the company operates through a network of more than 80 independent stocking distributors, over 40 independent sales agencies, and direct sales representatives across more than 75 countries. The company has made strategic acquisitions including ApiFix, MD Ortho, Pega Medical, Boston Brace International, and multiple orthotic and prosthetic clinics to expand its product portfolio and service capabilities. OrthoPediatrics estimates its addressable market represents a $6.2 billion global opportunity, including over $2.8 billion in the United States.
Company details
- Sector
- Healthcare
- Industry
- Surgical & Medical Instruments
- Headquarters
- WARSAW, IN
- Fiscal year end
- December
- CIK
- 1425450
- SIC
- 3841
Financial performance, year by year
Fiscal 2017–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns ORTHOPEDIATRICS CORP — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · ORTHOPEDIATRICS CORP’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do ORTHOPEDIATRICS CORP and its peers compare on margins and cash generation over ten years?”
- “Where did five years of ORTHOPEDIATRICS CORP's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in ORTHOPEDIATRICS CORP's last four quarterly filings that the numbers alone won't show?”